Trials / Completed
CompletedNCT03090399
Fluid ORiented Therapy for yoUNg Asa 1patients
Effects of the Goal-directed Fluid Therapy on ASA 1 Patients Scheduled for Intensive Debulking Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | FloTrac | For patients belonging to case group a Pulse Contour Analysis was adopted for optimize fluid administration |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2015-07-01
- Completion
- 2017-01-01
- First posted
- 2017-03-24
- Last updated
- 2017-03-24
Source: ClinicalTrials.gov record NCT03090399. Inclusion in this directory is not an endorsement.